Search Results - "Ohtaka, Kazuma"

A Rare Case of Granulomatous Mastitis in the Accessory Axillary Breast of a Pregnant Woman Successfully Treated by Surgery by Nakamura, Jun, Tanaka, Futoshi, Ohtaka, Kazuma, Sato, Ken, Iyama, Akihiro

“…Granulomatous mastitis (GM) is a chronic inflammatory disease of the breast that usually occurs in women of reproductive age. However, GM during pregnancy is…”
Get full text

Tumor–stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c‐Met pathway by Ide, Takao, Kitajima, Yoshihiko, Miyoshi, Atsushi, Ohtsuka, Takao, Mitsuno, Mayumi, Ohtaka, Kazuma, Koga, Yasuo, Miyazaki, Kohji

“…The hypoxic environment in tumor is reported to play an important role in pancreatic cancer progression. The interaction between stromal and cancer cells also…”
Get full text

The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling by Ide, Takao, Kitajima, Yoshihiko, Miyoshi, Atsushi, Ohtsuka, Takao, Mitsuno, Mayumi, Ohtaka, Kazuma, Miyazaki, Kohji

“…Pancreatic cancer is one of the representative solid tumors, in which the hypoxic microenvironment plays a crucial role in malignant progression. We previously…”
Get full text

Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients by Mitsuno, Mayumi, Kitajima, Yoshihiko, Ide, Takao, Ohtaka, Kazuma, Tanaka, Masayuki, Satoh, Seiji, Miyazaki, Kohji

“…Aberrant methylation of some cancer-related genes has been reported to correlate with sensitivity to chemotherapeutic agents. The present study was designed to…”
Get full text

Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer by KITAJIMA, Yoshihiko, OHTAKA, Kazuma, MITSUNO, Mayumi, TANAKA, Masayuki, SATO, Seiji, NAKAFUSA, Yuji, MIYAZAKI, Kohji

“…Runx3, a member of the human runt-related transcription factor family, is known as a possible tumor suppressor gene for gastric cancer. Runx 3 expression is…”
Get full text

CPT-11 (SN-38) Chemotherapy may be Selectively Applicable to Biliary Tract Cancer with Low hMLH1 Expression by SATO, Ken, KITAJIMA, Yoshihiko, KOHYA, Naohiko, KOGA, Yasuo, OHTAKA, Kazuma, MIYAZAKI, Kohji

“…Biliary tract cancer is of highly malignancy with a poor 5-year survival. However, established chemotherapeutic regimens have not yet been established…”
Get full text

Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1 by Mitsuno, Mayumi, Kitajima, Yoshihiko, Ohtaka, Kazuma, Kai, Keita, Hashiguchi, Kazuyoshi, Nakamura, Jun, Hiraki, Masatsugu, Noshiro, Hirokazu, Miyazaki, Kohji

“…Gemcitabine (Gem) is a dFdC analogue with activity against several solid tumors. Gem is intracellularly phosphorylated by dCK, leading to the production of the…”
Get full text

Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma by Ohtaka, Kazuma, Kohya, Naohiko, Sato, Ken, Kitajima, Yoshihiko, Ide, Takao, Mitsuno, Mayumi, Miyazaki, Kohji

“…Biliary tract carcinoma is a relatively rare tumor with a poor prognosis. Surgical resection is the only potential cure. However, the efficacy of…”
Get full text

Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1 by MITSUNO, Mayumi, KITAJIMA, Yoshihiko, OHTAKA, Kazuma, KAI, Keita, HASHIGUCHI, Kazuyoshi, NAKAMURA, Jun, HIRAKI, Masatsugu, NOSHIRO, Hirokazu, MIYAZAKI, Kohji

Get full text

Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer by Ide, Takao, Kitajima, Yoshihiko, Ohtaka, Kazuma, Mitsuno, Mayumi, Nakafusa, Yuji, Miyazaki, Kohji

“…The loss of a DNA mismatch repair occurs in approximately 15% of sporadic colorectal cancer (CRC) and is usually caused by the lack of expression of the hMLH1…”
Get full text

Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma by NAKAMURA, Jun, KOHYA, Naohiko, KAI, Keita, OHTAKA, Kazuma, HASHIGUCHI, Kazuyoshi, HIRAKI, Masatsugu, KITAJIMA, Yoshihiko, TOKUNAGA, Osamu, NOSHIRO, Hirokazu, MIYAZAKI, Kohji

“…Gemcitabine is a commonly used chemotherapeutic agent for advanced biliary tract carcinoma (BTC), although its efficacy is insufficient. Therefore, it is…”
Get full text

Ribonucleotide reductase subunit Ml is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma by OHTAKA, Kazuma, KOHYA, Naohiko, SATO, Ken, KITAJIMA, Yoshihiko, IDE, Takao, MITSUNO, Mayumi, MIYAZAKI, Kohji

Get full text

Expression of the hMLHI gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer by IDE, Takao, KITAJIMA, Yoshihiko, OHTAKA, Kazuma, MITSUNO, Mayumi, NAKAFUSA, Yuji, MIYAZAKI, Kohji

Get full text

A Rare Case of Granulomatous Mastitis in the Accessory Axillary Breast of a Pregnant Woman Successfully Treated by Surgery by Nakamura, Jun, Tanaka, Futoshi, Ohtaka, Kazuma, Sato, Ken, Iyama, Akihiro

Get full text